An Integrated Management Paradigm for Skull Base Chordoma Based on Clinical and Molecular Characteristics

Abstract excerpt

Abstract Objective Previous work categorized skull base chordoma (SBC) into three genetic risk groups based on 1p36 and homozygous 9p21(p16) deletions, accounting for a wide variability in prognosis (A = low-risk, B = intermediate-risk, C = high-risk). However, it remains unclear how these groups could guide management. Study Design By integrating surgical outcome and adjuvant radiation (AdjXRT) information with...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bone Tumor Diagnosis and Treatments
• Share to Oral and Maxillofacial Pathology
• Share to Sarcoma Diagnosis and Treatment